 There are more than one thousand deaths annually from head and neck cancer in Taiwan excluding nasopharyngeal carcinoma and the majority of treatment failures are related to recurrence of primary disease. Only patients with early-stage disease have high cure rates, but they remain at risk for the development of second primary tumors. 